According to Molina Healthcare 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 18.1649. At the end of 2021 the company had a P/E ratio of 28.0.
Year | P/E ratio | Change |
---|---|---|
2021 | 28.0 | 50.11% |
2020 | 18.6 | 61.82% |
2019 | 11.5 | 13.08% |
2018 | 10.2 | -217.2% |
2017 | -8.70 | -102.25% |
2016 | 387 | 1604.13% |
2015 | 22.7 | -45.35% |
2014 | 41.5 | 38.57% |
2013 | 30.0 | -76.75% |
2012 | 129 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
![]() Cigna CI | 11.4 | -37.42% | ๐บ๐ธ USA |
![]() Humana HUM | 22.2 | 22.06% | ๐บ๐ธ USA |
![]() Anthem ANTM | 18.8 | 3.32% | ๐บ๐ธ USA |
![]() Magellan Health
MGLN | N/A | N/A | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.